|
Volumn 28, Issue 3, 1996, Pages 1163-1167
|
Hepatitis C in kidney transplant patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
AZATHIOPRINE;
CYCLOSPORIN A;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS C ANTIBODY;
PREDNISOLONE;
VIRUS RNA;
ADULT;
CLINICAL FEATURE;
CONFERENCE PAPER;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT SURVIVAL;
HEMODIALYSIS;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LABORATORY TEST;
LIVER DYSFUNCTION;
LIVER FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
ALANINE TRANSAMINASE;
ASPARTATE AMINOTRANSFERASES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT SURVIVAL;
HEPACIVIRUS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVER FUNCTION TESTS;
MALE;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE COMPLICATIONS;
RENAL DIALYSIS;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 0029934346
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|